M Ohtsuki

1.5k total citations · 1 hit paper
14 papers, 1.3k citations indexed

About

M Ohtsuki is a scholar working on Molecular Biology, Organic Chemistry and Immunology. According to data from OpenAlex, M Ohtsuki has authored 14 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Organic Chemistry and 5 papers in Immunology. Recurrent topics in M Ohtsuki's work include Carbohydrate Chemistry and Synthesis (9 papers), Chemical Synthesis and Analysis (5 papers) and Signaling Pathways in Disease (3 papers). M Ohtsuki is often cited by papers focused on Carbohydrate Chemistry and Synthesis (9 papers), Chemical Synthesis and Analysis (5 papers) and Signaling Pathways in Disease (3 papers). M Ohtsuki collaborates with scholars based in Japan and United States. M Ohtsuki's co-authors include Kenji Chiba, Yukio Hoshino, Yoshiki Yanagawa, Takafumi Kawaguchi, Hirotoshi Kataoka, Takayuki Suzuki, Hiroaki Kataoka, Nobuharu Gotô, Yuichiro Amano and Yuji Masubuchi and has published in prestigious journals such as The Journal of Immunology, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

M Ohtsuki

14 papers receiving 1.3k citations

Hit Papers

FTY720, a Novel Immunosuppressant, Induces Sequestration ... 1998 2026 2007 2016 1998 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Ohtsuki Japan 14 1.0k 379 201 186 133 14 1.3k
Ewa Marcinkowska Poland 24 746 0.7× 184 0.5× 112 0.6× 201 1.1× 155 1.2× 71 1.3k
Laura Braccini Italy 8 880 0.8× 160 0.4× 52 0.3× 48 0.3× 239 1.8× 12 1.3k
Inge Tinhofer Austria 22 689 0.7× 393 1.0× 52 0.3× 115 0.6× 427 3.2× 50 1.4k
Laura Engstrom United States 9 557 0.5× 344 0.9× 61 0.3× 340 1.8× 260 2.0× 12 1.3k
Kevin J. French United States 14 1.4k 1.4× 165 0.4× 137 0.7× 41 0.2× 192 1.4× 17 1.6k
S. Sianna Castillo United States 13 1.0k 1.0× 183 0.5× 79 0.4× 53 0.3× 327 2.5× 14 1.4k
Lora B. Kramer United States 22 871 0.8× 91 0.2× 46 0.2× 230 1.2× 298 2.2× 34 1.2k
Darren C. Phillips United States 16 658 0.6× 206 0.5× 36 0.2× 239 1.3× 210 1.6× 40 1.1k
Peter Norman United Kingdom 18 436 0.4× 301 0.8× 138 0.7× 57 0.3× 202 1.5× 100 1.3k
Lynn Ueno United States 9 630 0.6× 126 0.3× 56 0.3× 52 0.3× 221 1.7× 13 910

Countries citing papers authored by M Ohtsuki

Since Specialization
Citations

This map shows the geographic impact of M Ohtsuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Ohtsuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Ohtsuki more than expected).

Fields of papers citing papers by M Ohtsuki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Ohtsuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Ohtsuki. The network helps show where M Ohtsuki may publish in the future.

Co-authorship network of co-authors of M Ohtsuki

This figure shows the co-authorship network connecting the top 25 collaborators of M Ohtsuki. A scholar is included among the top collaborators of M Ohtsuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Ohtsuki. M Ohtsuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Okada, Kosuke, Junichi Shoda, Keiko Taguchi, et al.. (2009). Nrf2 counteracts cholestatic liver injury via stimulation of hepatic defense systems. Biochemical and Biophysical Research Communications. 389(3). 431–436. 73 indexed citations
2.
Okada, Kosuke, Junichi Shoda, Keiko Taguchi, et al.. (2008). Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice. American Journal of Physiology-Gastrointestinal and Liver Physiology. 295(4). G735–G747. 123 indexed citations
3.
Kataoka, Hiroaki, M Ohtsuki, Kyoko Shimano, et al.. (2005). Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: II. Effect of FTY720 and FTY720-phosphate on host-versus-graft and graft-versus-host reaction in mice. Transplantation Proceedings. 37(1). 107–109. 14 indexed citations
4.
Chiba, Kenji, Yukio Hoshino, M Ohtsuki, et al.. (2005). Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: I. Prevention of allograft rejection in rats and dogs by FTY720 and FTY720-phosphate. Transplantation Proceedings. 37(1). 102–106. 24 indexed citations
5.
Nakajima, Masahide, Kazutaka Hayashi, Yasuhiro Egi, et al.. (2003). Effect of Wf-536, a novel ROCK inhibitor, against metastasis of B16 melanoma. Cancer Chemotherapy and Pharmacology. 52(4). 319–324. 70 indexed citations
6.
Kiuchi, Masatoshi, Kunitomo Adachi, Toshiyuki Kohara, et al.. (2000). Synthesis and Immunosuppressive Activity of 2-Substituted 2-Aminopropane-1,3-diols and 2-Aminoethanols. Journal of Medicinal Chemistry. 43(15). 2946–2961. 178 indexed citations
7.
Yanagawa, Yoshiki, Yukio Hoshino, Hiroaki Kataoka, et al.. (1999). FTY720, a novel immunosuppressant, prolongs rat skin allograft survival by decreasing T-Cell infiltration into grafts. Transplantation Proceedings. 31(1-2). 1227–1229. 32 indexed citations
8.
Hoshino, Yukio, et al.. (1999). FTY720, a novel immunosuppressant, shows a synergistic effect in combination with FK 506 in rat allograft models. Transplantation Proceedings. 31(1-2). 1224–1226. 27 indexed citations
9.
Chiba, Kenji, Yoshiki Yanagawa, Hiroaki Kataoka, et al.. (1999). FTY720, a novel immunosuppressant, induces sequestration of circulating lymphocytes by acceleration of lymphocyte homing. Transplantation Proceedings. 31(1-2). 1230–1233. 46 indexed citations
10.
Chiba, Kenji, Yoshiki Yanagawa, Hirotoshi Kataoka, et al.. (1998). FTY720, a Novel Immunosuppressant, Induces Sequestration of Circulating Mature Lymphocytes by Acceleration of Lymphocyte Homing in Rats. I. FTY720 Selectively Decreases the Number of Circulating Mature Lymphocytes by Acceleration of Lymphocyte Homing. The Journal of Immunology. 160(10). 5037–5044. 511 indexed citations breakdown →
11.
Kawaguchi, Takeshi, Yukio Hoshino, Fahad Imtiaz Rahman, et al.. (1996). FTY720, a novel immunosuppressant possessing unique mechanisms. III. Synergistic prolongation of canine renal allograft survival in combination with cyclosporine A.. PubMed. 28(2). 1062–3. 43 indexed citations
12.
Masubuchi, Yuji, M Ohtsuki, Takayuki Suzuki, et al.. (1996). FTY720, a novel immunosuppressant, possessing unique mechanisms. IV. Prevention of graft versus host reactions in rats.. PubMed. 28(2). 1064–5. 25 indexed citations
13.
Hoshino, Yukio, Takayuki Suzuki, M Ohtsuki, et al.. (1996). FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A.. PubMed. 28(2). 1060–1. 61 indexed citations
14.
Chiba, Kenji, Yukio Hoshino, Takayuki Suzuki, et al.. (1996). FTY720, a novel immunosuppressant possessing unique mechanisms. I. Prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rats.. PubMed. 28(2). 1056–9. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026